These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17511616)

  • 1. Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway.
    Gould TD; Dow ER; O'Donnell KC; Chen G; Manji HK
    CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):193-204. PubMed ID: 17511616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular signaling pathways pave roads to recovery for mood disorders.
    Tanis KQ; Duman RS
    Ann Med; 2007; 39(7):531-44. PubMed ID: 17852035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wnt signaling pathway in bipolar disorder.
    Gould TD; Manji HK
    Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between the Wnt signaling and the psychiatric diseases].
    Ferrero A; Cereseto M; Sifonios L
    Vertex; 2006; 17(67):165-71. PubMed ID: 16847474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders.
    Gould TD; Picchini AM; Einat H; Manji HK
    Curr Drug Targets; 2006 Nov; 7(11):1399-409. PubMed ID: 17100580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.
    Freyberg Z; Ferrando SJ; Javitch JA
    Am J Psychiatry; 2010 Apr; 167(4):388-96. PubMed ID: 19917593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
    Wada A
    J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
    Blankesteijn WM; van de Schans VA; ter Horst P; Smits JF
    Trends Pharmacol Sci; 2008 Apr; 29(4):175-80. PubMed ID: 18342376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
    Rao AS; Kremenevskaja N; Resch J; Brabant G
    Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression.
    Sato MM; Nakashima A; Nashimoto M; Yawaka Y; Tamura M
    Genes Cells; 2009 Feb; 14(2):141-53. PubMed ID: 19170762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRH and SRIF have opposite effects on the Wnt/β-catenin signalling pathway through PKA/GSK-3β in corticotroph pituitary cells.
    Khattak MN; Buchfelder M; Kleindienst A; Schöfl C; Kremenevskaja N
    Cancer Invest; 2010 Oct; 28(8):797-805. PubMed ID: 20690801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus.
    Orellana AM; Vasconcelos AR; Leite JA; de Sá Lima L; Andreotti DZ; Munhoz CD; Kawamoto EM; Scavone C
    Aging (Albany NY); 2015 Dec; 7(12):1094-111. PubMed ID: 26647069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for WNT/β-catenin signaling in the neural mechanisms of behavior.
    Maguschak KA; Ressler KJ
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):763-73. PubMed ID: 22415718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia.
    Cole AR
    FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wnt signaling and glucocorticoid-induced osteoporosis].
    Ohnaka K
    Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].
    Liu Y; Zhang CG; Zhou CY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):238-42. PubMed ID: 20396373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.